+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Oligonucleotide Synthesis Market 2023-2027

  • PDF Icon

    Report

  • 178 Pages
  • June 2023
  • Region: Global
  • TechNavio
  • ID: 5681602
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The oligonucleotide synthesis market is forecasted to grow by USD 2,870.69 mn during 2022-2027, accelerating at a CAGR of 13.47% during the forecast period. The report on the oligonucleotide synthesis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing research activities in pharmaceutical and biotechnology sectors, increasing use of oligonucleotides as therapeutic and diagnostic tools, and emergence of technological innovations in oligonucleotide synthesis.

The oligonucleotide synthesis market is segmented as below:

By Application

  • PCR primers
  • Flurorescence in situ hybridization
  • PCR assays and panels
  • DNA microarrays
  • Others

By End-user

  • Pharmaceutical and biotechnology companies
  • Research and academic institutes
  • Diagnostic laboratories
  • Hospitals

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing focus on R & D of new oligonucleotide therapeutics as one of the prime reasons driving the oligonucleotide synthesis market growth during the next few years. Also, increasing research funding and rise in demand for low-cost and high-throughput oligonucleotide synthesis will lead to sizable demand in the market.

The report on the oligonucleotide synthesis market covers the following areas:

  • Oligonucleotide synthesis market sizing
  • Oligonucleotide synthesis market forecast
  • Oligonucleotide synthesis market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oligonucleotide synthesis market vendors that include Agilent Technologies Inc., Ajinomoto Co. Inc., Alnylam Pharmaceuticals Inc., Bio Synthesis Inc, Biocon Ltd., Biotage AB, Danaher Corp., Eurofins Scientific SE, General Electric Co., Ionis Pharmaceuticals Inc., Kaneka Corp., LGC Science Group Holdings Ltd., Maravai LifeSciences Holdings Inc., Merck KGaA, Mettler Toledo International Inc., QIAGEN NV, Sarepta Therapeutics Inc, Synbio Technologies, Thermo Fisher Scientific Inc., and Biogen Inc.. Also, the oligonucleotide synthesis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global oligonucleotide synthesis market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global oligonucleotide synthesis market 2017 - 2021 ($ billion)
4.2 Applications Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Applications Segment 2017 - 2021 ($ billion)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 PCR primers - Market size and forecast 2022-2027
Exhibit 34: Chart on PCR primers - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on PCR primers - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on PCR primers - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on PCR primers - Year-over-year growth 2022-2027 (%)
6.4 Fluorescence in situ hybridization - Market size and forecast 2022-2027
Exhibit 38: Chart on Fluorescence in situ hybridization - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Fluorescence in situ hybridization - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Fluorescence in situ hybridization - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Fluorescence in situ hybridization - Year-over-year growth 2022-2027 (%)
6.5 PCR assays and panels - Market size and forecast 2022-2027
Exhibit 42: Chart on PCR assays and panels - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on PCR assays and panels - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on PCR assays and panels - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on PCR assays and panels - Year-over-year growth 2022-2027 (%)
6.6 DNA microarrays - Market size and forecast 2022-2027
Exhibit 46: Chart on DNA microarrays - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on DNA microarrays - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on DNA microarrays - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on DNA microarrays - Year-over-year growth 2022-2027 (%)
6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Application
Exhibit 54: Market opportunity by Application ($ billion)
Exhibit 55: Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 56: Chart on End-user - Market share 2022-2027 (%)
Exhibit 57: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 58: Chart on Comparison by End-user
Exhibit 59: Data Table on Comparison by End-user
7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
Exhibit 60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
7.4 Research and academic institutes - Market size and forecast 2022-2027
Exhibit 64: Chart on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Data Table on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Chart on Research and academic institutes - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Research and academic institutes - Year-over-year growth 2022-2027 (%)
7.5 Diagnostic laboratories - Market size and forecast 2022-2027
Exhibit 68: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
7.6 Hospitals - Market size and forecast 2022-2027
Exhibit 72: Chart on Hospitals - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Data Table on Hospitals - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 75: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by End-user
Exhibit 76: Market opportunity by End-user ($ billion)
Exhibit 77: Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 79: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 81: Chart on Geographic comparison
Exhibit 82: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 83: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 87: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 91: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 99: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 111: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 112: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 113: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 115: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 116: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 117: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 118: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 119: Market opportunity By Geographical Landscape ($ billion)
Exhibit 120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 121: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 123: Overview on factors of disruption
11.4 Industry risks
Exhibit 124: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 125: Vendors covered
12.2 Market positioning of vendors
Exhibit 126: Matrix on vendor position and classification
12.3 Agilent Technologies Inc.
Exhibit 127: Agilent Technologies Inc. - Overview
Exhibit 128: Agilent Technologies Inc. - Business segments
Exhibit 129: Agilent Technologies Inc. - Key offerings
Exhibit 130: Agilent Technologies Inc. - Segment focus
12.4 Alnylam Pharmaceuticals Inc.
Exhibit 131: Alnylam Pharmaceuticals Inc. - Overview
Exhibit 132: Alnylam Pharmaceuticals Inc. - Product/Service
Exhibit 133: Alnylam Pharmaceuticals Inc. - Key news
Exhibit 134: Alnylam Pharmaceuticals Inc. - Key offerings
12.5 Biogen Inc.
Exhibit 135: Biogen Inc. - Overview
Exhibit 136: Biogen Inc. - Product/Service
Exhibit 137: Biogen Inc. - Key offerings
12.6 Biotage AB
Exhibit 138: Biotage AB - Overview
Exhibit 139: Biotage AB - Product/Service
Exhibit 140: Biotage AB - Key news
Exhibit 141: Biotage AB - Key offerings
12.7 Danaher Corp.
Exhibit 142: Danaher Corp. - Overview
Exhibit 143: Danaher Corp. - Business segments
Exhibit 144: Danaher Corp. - Key news
Exhibit 145: Danaher Corp. - Key offerings
Exhibit 146: Danaher Corp. - Segment focus
12.8 Eurofins Scientific SE
Exhibit 147: Eurofins Scientific SE - Overview
Exhibit 148: Eurofins Scientific SE - Business segments
Exhibit 149: Eurofins Scientific SE - Key news
Exhibit 150: Eurofins Scientific SE - Key offerings
Exhibit 151: Eurofins Scientific SE - Segment focus
12.9 Ionis Pharmaceuticals Inc.
Exhibit 152: Ionis Pharmaceuticals Inc. - Overview
Exhibit 153: Ionis Pharmaceuticals Inc. - Business segments
Exhibit 154: Ionis Pharmaceuticals Inc. - Key news
Exhibit 155: Ionis Pharmaceuticals Inc. - Key offerings
Exhibit 156: Ionis Pharmaceuticals Inc. - Segment focus
12.10 Kaneka Corp.
Exhibit 157: Kaneka Corp. - Overview
Exhibit 158: Kaneka Corp. - Business segments
Exhibit 159: Kaneka Corp. - Key offerings
Exhibit 160: Kaneka Corp. - Segment focus
12.11 LGC Science Group Holdings Ltd.
Exhibit 161: LGC Science Group Holdings Ltd. - Overview
Exhibit 162: LGC Science Group Holdings Ltd. - Product/Service
Exhibit 163: LGC Science Group Holdings Ltd. - Key offerings
12.12 Maravai LifeSciences Holdings Inc.
Exhibit 164: Maravai LifeSciences Holdings Inc. - Overview
Exhibit 165: Maravai LifeSciences Holdings Inc. - Business segments
Exhibit 166: Maravai LifeSciences Holdings Inc. - Key offerings
Exhibit 167: Maravai LifeSciences Holdings Inc. - Segment focus
12.13 Merck KGaA
Exhibit 168: Merck KGaA - Overview
Exhibit 169: Merck KGaA - Business segments
Exhibit 170: Merck KGaA - Key news
Exhibit 171: Merck KGaA - Key offerings
Exhibit 172: Merck KGaA - Segment focus
12.14 Mettler Toledo International Inc.
Exhibit 173: Mettler Toledo International Inc. - Overview
Exhibit 174: Mettler Toledo International Inc. - Business segments
Exhibit 175: Mettler Toledo International Inc. - Key offerings
Exhibit 176: Mettler Toledo International Inc. - Segment focus
12.15 Sarepta Therapeutics Inc
Exhibit 177: Sarepta Therapeutics Inc - Overview
Exhibit 178: Sarepta Therapeutics Inc - Product/Service
Exhibit 179: Sarepta Therapeutics Inc - Key offerings
12.16 Synbio Technologies
Exhibit 180: Synbio Technologies - Overview
Exhibit 181: Synbio Technologies - Product/Service
Exhibit 182: Synbio Technologies - Key offerings
12.17 Thermo Fisher Scientific Inc.
Exhibit 183: Thermo Fisher Scientific Inc. - Overview
Exhibit 184: Thermo Fisher Scientific Inc. - Business segments
Exhibit 185: Thermo Fisher Scientific Inc. - Key news
Exhibit 186: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 187: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 188: Inclusions checklist
Exhibit 189: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 190: Currency conversion rates for US$
13.4 Research methodology
Exhibit 191: Research methodology
Exhibit 192: Validation techniques employed for market sizing
Exhibit 193: Information sources
13.5 List of abbreviations
Exhibit 194: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global oligonucleotide synthesis market 2017 - 2021 ($ billion)
Exhibits 19: Historic Market Size - Applications Segment 2017 - 2021 ($ billion)
Exhibits 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Application - Market share 2022-2027 (%)
Exhibits 31: Data Table on Application - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on PCR primers - Market size and forecast 2022-2027 ($ billion)
Exhibits 35: Data Table on PCR primers - Market size and forecast 2022-2027 ($ billion)
Exhibits 36: Chart on PCR primers - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on PCR primers - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Fluorescence in situ hybridization - Market size and forecast 2022-2027 ($ billion)
Exhibits 39: Data Table on Fluorescence in situ hybridization - Market size and forecast 2022-2027 ($ billion)
Exhibits 40: Chart on Fluorescence in situ hybridization - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Fluorescence in situ hybridization - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on PCR assays and panels - Market size and forecast 2022-2027 ($ billion)
Exhibits 43: Data Table on PCR assays and panels - Market size and forecast 2022-2027 ($ billion)
Exhibits 44: Chart on PCR assays and panels - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on PCR assays and panels - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on DNA microarrays - Market size and forecast 2022-2027 ($ billion)
Exhibits 47: Data Table on DNA microarrays - Market size and forecast 2022-2027 ($ billion)
Exhibits 48: Chart on DNA microarrays - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on DNA microarrays - Year-over-year growth 2022-2027 (%)
Exhibits 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 54: Market opportunity by Application ($ billion)
Exhibits 55: Data Table on Market opportunity by Application ($ billion)
Exhibits 56: Chart on End-user - Market share 2022-2027 (%)
Exhibits 57: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 58: Chart on Comparison by End-user
Exhibits 59: Data Table on Comparison by End-user
Exhibits 60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ billion)
Exhibits 61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ billion)
Exhibits 62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits 64: Chart on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
Exhibits 65: Data Table on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
Exhibits 66: Chart on Research and academic institutes - Year-over-year growth 2022-2027 (%)
Exhibits 67: Data Table on Research and academic institutes - Year-over-year growth 2022-2027 (%)
Exhibits 68: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ billion)
Exhibits 69: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ billion)
Exhibits 70: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 71: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 72: Chart on Hospitals - Market size and forecast 2022-2027 ($ billion)
Exhibits 73: Data Table on Hospitals - Market size and forecast 2022-2027 ($ billion)
Exhibits 74: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 75: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 76: Market opportunity by End-user ($ billion)
Exhibits 77: Data Table on Market opportunity by End-user ($ billion)
Exhibits 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 79: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 81: Chart on Geographic comparison
Exhibits 82: Data Table on Geographic comparison
Exhibits 83: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 84: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 85: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 88: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 92: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 93: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 100: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 101: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 111: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits 112: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits 113: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 114: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 115: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits 116: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits 117: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 118: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 119: Market opportunity By Geographical Landscape ($ billion)
Exhibits 120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 121: Impact of drivers and challenges in 2022 and 2027
Exhibits 122: Overview on Criticality of inputs and Factors of differentiation
Exhibits 123: Overview on factors of disruption
Exhibits 124: Impact of key risks on business
Exhibits 125: Vendors covered
Exhibits 126: Matrix on vendor position and classification
Exhibits 127: Agilent Technologies Inc. - Overview
Exhibits 128: Agilent Technologies Inc. - Business segments
Exhibits 129: Agilent Technologies Inc. - Key offerings
Exhibits 130: Agilent Technologies Inc. - Segment focus
Exhibits 131: Alnylam Pharmaceuticals Inc. - Overview
Exhibits 132: Alnylam Pharmaceuticals Inc. - Product/Service
Exhibits 133: Alnylam Pharmaceuticals Inc. - Key news
Exhibits 134: Alnylam Pharmaceuticals Inc. - Key offerings
Exhibits 135: Biogen Inc. - Overview
Exhibits 136: Biogen Inc. - Product/Service
Exhibits 137: Biogen Inc. - Key offerings
Exhibits 138: Biotage AB - Overview
Exhibits 139: Biotage AB - Product/Service
Exhibits 140: Biotage AB - Key news
Exhibits 141: Biotage AB - Key offerings
Exhibits 142: Danaher Corp. - Overview
Exhibits 143: Danaher Corp. - Business segments
Exhibits 144: Danaher Corp. - Key news
Exhibits 145: Danaher Corp. - Key offerings
Exhibits 146: Danaher Corp. - Segment focus
Exhibits 147: Eurofins Scientific SE - Overview
Exhibits 148: Eurofins Scientific SE - Business segments
Exhibits 149: Eurofins Scientific SE - Key news
Exhibits 150: Eurofins Scientific SE - Key offerings
Exhibits 151: Eurofins Scientific SE - Segment focus
Exhibits 152: Ionis Pharmaceuticals Inc. - Overview
Exhibits 153: Ionis Pharmaceuticals Inc. - Business segments
Exhibits 154: Ionis Pharmaceuticals Inc. - Key news
Exhibits 155: Ionis Pharmaceuticals Inc. - Key offerings
Exhibits 156: Ionis Pharmaceuticals Inc. - Segment focus
Exhibits 157: Kaneka Corp. - Overview
Exhibits 158: Kaneka Corp. - Business segments
Exhibits 159: Kaneka Corp. - Key offerings
Exhibits 160: Kaneka Corp. - Segment focus
Exhibits 161: LGC Science Group Holdings Ltd. - Overview
Exhibits 162: LGC Science Group Holdings Ltd. - Product/Service
Exhibits 163: LGC Science Group Holdings Ltd. - Key offerings
Exhibits 164: Maravai LifeSciences Holdings Inc. - Overview
Exhibits 165: Maravai LifeSciences Holdings Inc. - Business segments
Exhibits 166: Maravai LifeSciences Holdings Inc. - Key offerings
Exhibits 167: Maravai LifeSciences Holdings Inc. - Segment focus
Exhibits 168: Merck KGaA - Overview
Exhibits 169: Merck KGaA - Business segments
Exhibits 170: Merck KGaA - Key news
Exhibits 171: Merck KGaA - Key offerings
Exhibits 172: Merck KGaA - Segment focus
Exhibits 173: Mettler Toledo International Inc. - Overview
Exhibits 174: Mettler Toledo International Inc. - Business segments
Exhibits 175: Mettler Toledo International Inc. - Key offerings
Exhibits 176: Mettler Toledo International Inc. - Segment focus
Exhibits 177: Sarepta Therapeutics Inc - Overview
Exhibits 178: Sarepta Therapeutics Inc - Product/Service
Exhibits 179: Sarepta Therapeutics Inc - Key offerings
Exhibits 180: Synbio Technologies - Overview
Exhibits 181: Synbio Technologies - Product/Service
Exhibits 182: Synbio Technologies - Key offerings
Exhibits 183: Thermo Fisher Scientific Inc. - Overview
Exhibits 184: Thermo Fisher Scientific Inc. - Business segments
Exhibits 185: Thermo Fisher Scientific Inc. - Key news
Exhibits 186: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 187: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 188: Inclusions checklist
Exhibits 189: Exclusions checklist
Exhibits 190: Currency conversion rates for US$
Exhibits 191: Research methodology
Exhibits 192: Validation techniques employed for market sizing
Exhibits 193: Information sources
Exhibits 194: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global oligonucleotide synthesis market: Agilent Technologies Inc., Ajinomoto Co. Inc., Alnylam Pharmaceuticals Inc., Bio Synthesis Inc, Biocon Ltd., Biotage AB, Danaher Corp., Eurofins Scientific SE, General Electric Co., Ionis Pharmaceuticals Inc., Kaneka Corp., LGC Science Group Holdings Ltd., Maravai LifeSciences Holdings Inc., Merck KGaA, Mettler Toledo International Inc., QIAGEN NV, Sarepta Therapeutics Inc, Synbio Technologies, Thermo Fisher Scientific Inc., and Biogen Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing focus on R & D of new oligonucleotide therapeutics.'

According to the report, one of the major drivers for this market is the increasing research activities in pharmaceutical and biotechnology sectors.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies Inc.
  • Ajinomoto Co. Inc.
  • Alnylam Pharmaceuticals Inc.
  • Bio Synthesis Inc
  • Biocon Ltd.
  • Biotage AB
  • Danaher Corp.
  • Eurofins Scientific SE
  • General Electric Co.
  • Ionis Pharmaceuticals Inc.
  • Kaneka Corp.
  • LGC Science Group Holdings Ltd.
  • Maravai LifeSciences Holdings Inc.
  • Merck KGaA
  • Mettler Toledo International Inc.
  • QIAGEN NV
  • Sarepta Therapeutics Inc
  • Synbio Technologies
  • Thermo Fisher Scientific Inc.
  • Biogen Inc.

Related Topics

Related Reports

Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides. 2023 to 2027 - Product Image

Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides. 2023 to 2027

  • Report
  • 352 Pages
  • Global
From
Oligonucleotide Synthesis Global Market Report 2024 - Product Image

Oligonucleotide Synthesis Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 149 Pages
  • Global
From
RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious Diseases, Rare Genetic Diseases), End User (Hospitals & Clinics) - Global Forecast to 2028 - Product Image

RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious Diseases, Rare Genetic Diseases), End User (Hospitals & Clinics) - Global Forecast to 2028

  • Report
  • Global
From
Global Oligonucleotide Synthesis Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Oligonucleotide Synthesis Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.